BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: García-Compeán D, González-González JA, Lavalle-González FJ, González-Moreno EI, Villarreal-Pérez JZ, Maldonado-Garza HJ. Hepatogenous diabetes: Is it a neglected condition in chronic liver disease? World J Gastroenterol 2016; 22(10): 2869-2874 [PMID: 26973383 DOI: 10.3748/wjg.v22.i10.2869]
URL: https://www.wjgnet.com/1007-9327/full/v22/i10/2869.htm
Number Citing Articles
1
Manuela Maria de Lima Carvalhal, Jeane Lorena Lima Dias, Daniela Lopes Gomes, Juarez Antônio Simões Quaresma. Hepatitis C virus eradication on glycemic control and insulin resistanceRevista da Associação Médica Brasileira 2021; 67(12): 1821 doi: 10.1590/1806-9282.20210752
2
Abd Elkhalek Hamed, Nadia Elwan, Mervat Naguib, Reda Elwakil, Gamal Esmat, Mohamed El Kassas, Sherief Abd-Elsalam, Shorouk Moussa. Diabetes Association with Liver Diseases: An Overview for CliniciansEndocrine, Metabolic & Immune Disorders - Drug Targets 2019; 19(3): 274 doi: 10.2174/1871530318666181116111945
3
Laura I. Coman, Oana A. Coman, Ioana A. Bădărău, Horia Păunescu, Mihai Ciocîrlan. Association between Liver Cirrhosis and Diabetes Mellitus: A Review on Hepatic OutcomesJournal of Clinical Medicine 2021; 10(2): 262 doi: 10.3390/jcm10020262
4
Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, Elisabetta Bugianesi. Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver DiseaseMetabolites 2021; 11(3): 155 doi: 10.3390/metabo11030155
5
Lung-Wen Tsai, Yi-Hsiang Lu, Rajni Dubey, Jeng-Fong Chiou, Ilias Migdalis. Reenvisioning Traditional to Regenerative Therapeutic Advances in Managing Nonalcoholic Fatty Liver Disease in Diabetes MellitusJournal of Diabetes Research 2021; 2021: 1 doi: 10.1155/2021/7692447
6
Anchalia Chandrakumaran, Mohammad Shadab Siddiqui. Implications of Nonalcoholic Steatohepatitis as the Cause of End-Stage Liver Disease Before and After Liver TransplantGastroenterology Clinics of North America 2020; 49(1): 165 doi: 10.1016/j.gtc.2019.09.005
7
Valeria Grancini, Irene Cogliati, Gianfranco Alicandro, Alessia Gaglio, Stefano Gatti, Maria Francesca Donato, Emanuela Orsi, Veronica Resi. Assessment of hepatic fibrosis with non-invasive indices in subjects with diabetes before and after liver transplantationFrontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1359960
8
Marco Infante, Nathalia Padilla, SriGita Madiraju, Ana Alvarez, David Baidal, Camillo Ricordi, Rodolfo Alejandro. Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas2020; : 439 doi: 10.1016/B978-0-12-814833-4.00037-X
9
Emanuela Orsi, Valeria Grancini, Stefano Menini, Alessio Aghemo, Giuseppe Pugliese. Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?Liver International 2017; 37(7): 950 doi: 10.1111/liv.13337
10
Mandeep Kumar Singh, Bhrigu Kumar Das, Sandeep Choudhary, Deepak Gupta, Umesh K Patil. Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological managementBiomedicine & Pharmacotherapy 2018; 106: 991 doi: 10.1016/j.biopha.2018.06.095
11
Mona Mahmoud Hassouna, Mohammed Sayed Moustafa, Mona Hamdy, Eman Abdelsameea, Mohamed Abbasy, Mary Naguib. Study of transcription factor 7-like 2 (TCF7L2) gene polymorphism in cirrhotic patients with diabetesEgyptian Liver Journal 2023; 13(1) doi: 10.1186/s43066-023-00285-5
12
Farzana Shafqat, Muhammad Naeem A. Khan, Sarah Shafqat. IoT in Healthcare and Ambient Assisted LivingStudies in Computational Intelligence 2021; 933: 43 doi: 10.1007/978-981-15-9897-5_3
13
Doaa I. Mohamed, Enas S. Nabih, Dalia A.A. El-Waseef, Omnyah A. El-Kharashi, Abeer A. Abd El Samad. The protective effect of pentoxifylline versus silymarin on the pancreas through increasing adenosine by CD39 in a rat model of liver cirrhosis: Pharmacological, biochemical and histological studyGene 2018; 651: 9 doi: 10.1016/j.gene.2018.02.001
14
Jiang Zhang, Julia Schewe, Hanwei Li, Marie-Christine Makeschin, Ujjwal M. Mahajan, Alexander L. Gerbes, Christian J. Steib. The effects of hepatic steatosis on thromboxane A2 induced portal hypertensionGastroenterología y Hepatología 2019; 42(9): 534 doi: 10.1016/j.gastrohep.2019.03.015
15
Valeria Grancini, Veronica Resi, Eva Palmieri, Giuseppe Pugliese, Emanuela Orsi. Management of diabetes mellitus in patients undergoing liver transplantationPharmacological Research 2019; 141: 556 doi: 10.1016/j.phrs.2019.01.042
16
Shuwen Zhong, Zhaohui Deng, Lirong Jiang, Jingqing Zeng, Tingting Yu. Wilson’s Disease with Hepatogenous Diabetes: A Case ReportIranian Journal of Pediatrics 2021; 31(2) doi: 10.5812/ijp.105261
17
Diego García-Compeán, Emanuela Orsi, Ramesh Kumar, Felix Gundling, Tsutomu Nishida, Jesús Zacarías Villarreal-Pérez, Ángel N Del Cueto-Aguilera, José A González-González, Giuseppe Pugliese. Clinical implications of diabetes in chronic liver disease: Diagnosis, outcomes and management, current and future perspectivesWorld Journal of Gastroenterology 2022; 28(8): 775-793 doi: 10.3748/wjg.v28.i8.775
18
Yasmin Saad, Abobakr Awad, Wafaa Alakel, Wahid Doss, Tahany Awad, Mahasen Mabrouk. Data mining of routine laboratory tests can predict liver disease progression in Egyptian diabetic patients with hepatitis C virus (G4) infection: a cohort study of 71 806 patientsEuropean Journal of Gastroenterology & Hepatology 2018; 30(2): 201 doi: 10.1097/MEG.0000000000001008
19
Valeria Grancini, Maddalena Trombetta, Maria Elena Lunati, Maria Linda Boselli, Stefano Gatti, Maria Francesca Donato, Eva Palmieri, Veronica Resi, Giuseppe Pugliese, Riccardo C. Bonadonna, Emanuela Orsi. Central role of the β-cell in driving regression of diabetes after liver transplantation in cirrhotic patientsJournal of Hepatology 2019; 70(5): 954 doi: 10.1016/j.jhep.2019.01.015
20
Preetam Nath, Anil C. Anand. Hepatogenous Diabetes: A PrimerJournal of Clinical and Experimental Hepatology 2021; 11(5): 603 doi: 10.1016/j.jceh.2021.04.012
21
Jiang Zhang, Julia Schewe, Hanwei Li, Marie-Christine Makeschin, Ujjwal M. Mahajan, Alexander L. Gerbes, Christian J. Steib. The effects of hepatic steatosis on thromboxane A2 induced portal hypertensionGastroenterología y Hepatología (English Edition) 2019; 42(9): 534 doi: 10.1016/j.gastre.2019.03.021
22
Praveen Vasepalli, Mohd T. Noor, Bhagwan S. Thakur. Hepatogenous Diabetes - A Report from Central IndiaJournal of Clinical and Experimental Hepatology 2022; 12(2): 312 doi: 10.1016/j.jceh.2021.08.018
23
Azam Eshaghian, Ameneh Khodarahmi, Fatemeh Safari, Fariba Binesh, Ali Moradi. Curcumin attenuates hepatic fibrosis and insulin resistance induced by bile duct ligation in ratsBritish Journal of Nutrition 2018; 120(4): 393 doi: 10.1017/S0007114518001095
24
Yingying Zhao, Huichun Xing. A Different Perspective for Management of Diabetes Mellitus: Controlling Viral Liver DiseasesJournal of Diabetes Research 2017; 2017: 1 doi: 10.1155/2017/5625371
25
Abd Elkhalek Hamed, Medhat Elsahar, Nadia M. Elwan, Sarah El-Nakeep, Mervat Naguib, Hanan Hamed Soliman, Ashraf Ahmed Aboubakr, Amany AbdelMaqsod, Heba Sedrak, Samir N. Assaad, Reda Elwakil, Gamal Esmat, Samira Salh, Taymour Mostafa, Sherif Mogawer, Sameh Emil Sadek, Maha M. Saber, Hanan Ezelarab, Asem Ashraf Mahmoud, Souad Sultan, Mohamed El Kassas, Ehab Kamal, Naglaa M. ElSayed, Shorouk moussa. Managing diabetes and liver disease associationArab Journal of Gastroenterology 2018; 19(4): 166 doi: 10.1016/j.ajg.2018.08.003
26
Felix Gundling. Der hepatogene Diabetes – aktueller Stand der Diagnostik und TherapieJournal für Klinische Endokrinologie und Stoffwechsel 2022; 15(2): 42 doi: 10.1007/s41969-022-00158-z
27
Ramesh Kumar, Diego García-Compeán, Tanmoy Maji. Hepatogenous diabetes: Knowledge, evidence, and skepticismWorld Journal of Hepatology 2022; 14(7): 1291-1306 doi: 10.4254/wjh.v14.i7.1291